You are currently logged into
Cancer Health Directory - My Account or Log Out
Cancer Health Cancer Health
  • Home
  • News
    • News
    • Newsfeed
    • Treatment News
    • Features
    • Opinions
    • Conferences
    • Slideshows
    • Cancer Health TV
    • By Author
    • RSS Links
  • Cancer Basics
    • Cancer 101
    • Newly Diagnosed
    • Living with Cancer
    • Cancer Treatment
    • Cancer Medications
    • Breast Cancer
    • Colon Cancer
    • Liver Cancer
    • Lung Cancer
    • Prostate Cancer
    • More Types of Cancer
    • Resources
  • Hot Topics
    • Coronavirus (COVID-19)
    • Health Equity
    • Cancer Treatment
    • Car-T Therapy
    • Caregivers
    • Chemotherapy
    • Immunotherapy
    • Marijuana
    • Mental Health
    • Quality of Life
  • Magazine
    • Magazine
    • Current Issue
    • Archives
    • Digital Editions
    • Cancer Health Focus
    • Bulk Subscriptions
    • Email Newsletters
  • Blogs
    • Blogs
    • Recent Posts
    • Browse Bloggers
    • RSS Links
  • Community
    • Cancer Health Stories
    • Cancer Health Forums
    • Ask Cancer Health
    • Polls
    • Surveys
    • Quizzes
    • Calendar
    • Volunteer Jobs
    • Bookstore
    • Amazon Store
  • About Us
    • About Us
    • Masthead
    • Advertise
    • Awards
    • Contact Us
  • Facebook
  • Twitter

© 2021 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

© 2021 Smart + Strong.
All Rights Reserved.
Terms of use and
Your privacy.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.

Advertisement

Share


Twitter
Facebook
Pinterest
Tumblr
Email

#genes

Tweet
  • Share

Study of “Exceptional Responders” Yields Clues to Cancer and Potential Treatments

A genomic study has uncovered molecular changes in tumors that may lead to dramatic and long-lasting responses to cancer therapy.

New Test Measures Prostate Cancer Metastasis Risk

The benefits? Risk is assessed more rapidly and at a cheaper cost.

The National Academy of Sciences award for excellence in molecular biology

2018 National Academy of Sciences Award

Damon Runyon alumnus and mentor Howard Y. Chang, MD, PhD, of Stanford University School of Medicine, receives the award in Molecular Biology

Gene Associated With Metastatic Melanoma Identified

Researchers found that 80 percent of patient tumors had elevated levels of the protein GDF6, which correlated to the cancer’s aggressiveness

Breast Cancer Gene Test Can Predict Who Can Safely Skip Chemo

Some women with early-stage breast cancer may be able to cure the disease with hormone therapy alone.

Advertisement

Stay Logged In?

You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.

You Have Been Logged Out

Click here to log back in.